Effects of Multivitamin Supplementation on Anxiety and Depression in Methadone Meintenance Treatment Patientsin Urmia Razi Hospital Addiction Rehabilitation Clinic :A RandomiezedClinical Trial

Phase 3

• Conditions: Condition 1: Opioid Induced Anxiety Disorder. Condition 2: Opioid Induced Depressive Disorder.; Opioid abuse with other opioid-induced disorder; Opioid abuse with opioid-induced mood disorder; F11.188; F11.14

• Registration Number: IRCT20200726048210N1
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 70

Inclusion Criteria

Male
Age 18 or above
Are under methadone medication as part of an overall treatment against drug abuse
Have been referred to the opioid addiction treatment centre at urmia's razi hospital

Exclusion Criteria

Patients with stress and mood disorders that are being treated with antidepressant medication.
Patients who have high score in beck‘s depression inventory and beck‘sAnxiety inventory test will be refered to a psychiatrist and will be removed from the study when they start taking antidepression ans anti stress medication.
The pre-existence of uncontrolled metabolic disease .
The simultaneus consumption of any food supplement.
Having coeliac disease.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score of depression in Beck's depression inventory. Timepoint: Before intervention and 12 weeks after intervention( end of intervention). Method of measurement: Beck‘s Depression Inventory.;Score of Anxiety in Beck's anxiety inventory. Timepoint: Before intervention and 12 weeks after intervention( end of intervention). Method of measurement: Beck‘s Anxiety Inventory.